Freestyle Libre data
The mean (± SD) CGM wearing rate was not significantly different between the Omnipod group and the A7+TouchCare group at each visit: 91.3±11.4% vs. 90.0±13.6% (p = 0.625) at inclusion, 94.5±7.0% vs.91.6±11.8% (p = 0.200) at Visit 2, and 91.3±11.3% vs. 89.2±19.4% (p = 0.568) at Visit 3.Regardless of devices, the average glucose level remained stable between inclusion (165.2±27.2 mg/dL) and Visit 3 (164.2±22.7 mg/dL) without statistically significant difference between groups (p = 0.932) (